Physician profile
Caroline Price
NPI 1669463030
$8,872.03
in general payments reported to CMS, 2019-2025
38 companies · $2,228 in 2025
The $2,228 reported for 2025 was more than what 78% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $897 · 2020: $891 · 2021: $1,008 · 2022: $1,287 · 2023: $1,259 · 2024: $1,302 · 2025: $2,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,427 · Education: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,427.48 |
| Education | $361.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,285.41 | 2019-2025 | Tremfya, Simponi, Stelara |
| Sun Pharmaceutical Industries INC. | $1,196.05 | 2020-2025 | Ilumya, Winlevi |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $692.89 | 2019-2025 | Duobrii, Siliq |
| Incyte Corporation | $634.78 | 2021-2025 | Opzelura |
| Abbvie INC. | $607.65 | 2019-2025 | |
| Lilly USA, LLC | $605.65 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Pfizer INC. | $400.46 | 2019-2025 | |
| Galderma Laboratories, L.P. | $368.65 | 2019-2025 | Nemluvio, Aklief |
| Novartis Pharmaceuticals Corporation | $304.52 | 2019-2025 | |
| Dermavant Sciences, INC. | $278.99 | 2023-2024 | Vtama |
| Almirall LLC | $219.71 | 2019-2024 | Klisyri |
| Arcutis Biotherapeutics, INC. | $206.89 | 2023-2025 | Zoryve |
| Sandoz INC. | $194.93 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $180.03 | 2022-2025 | Sotyktu |
| Amgen INC. | $179.88 | 2020-2025 | Otezla, Otezla |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.